• Replimune Group Inc. (REPL) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com Thu, 09 Jul 2026 23:33:53 GMT

• 9 Health Care Stocks With Whale Alerts In Today’s Session Benzinga Thu, 09 Jul 2026 17:35:08 GMT

• REPL Stock On Track For Worst Drop In Nearly 7 Months Ahead Of FDA Decision On Skin Cancer Drug Stocktwits Thu, 09 Jul 2026 06:43:53 GMT

• replimune group stock and its cancer immunotherapy pipeline AD HOC NEWS Wed, 08 Jul 2026 14:31:39 GMT

• 3 Biotech Stocks to Watch Before Wall Street Catches On TradingView Wed, 08 Jul 2026 14:15:51 GMT

• Replimune surges on plans to resubmit lead drug for FDA review MSN Tue, 07 Jul 2026 20:54:44 GMT

• REPL Stock Lost 19% Of Its Value Today – Why Did The FDA Refuse Approval For Its Experimental Melanoma Drug? Stocktwits Tue, 07 Jul 2026 04:11:13 GMT

• REPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays Stocktwits Tue, 07 Jul 2026 02:42:03 GMT

• repl stock on track to hit all-time lows – here’s why this analyst slashed price target by 85% Stocktwits Sun, 05 Jul 2026 17:40:10 GMT

• the week in pharma: action, reaction and insight – week to july 3, 2026 The Pharma Letter Sun, 05 Jul 2026 10:53:06 GMT

• repl stock lost 19% of its value today – why did the fda refuse approval for its experimental melanoma drug? Stocktwits Fri, 03 Jul 2026 18:35:06 GMT

• Replimune says FDA rejected its lead drug for skin cancer MSN Fri, 03 Jul 2026 17:52:33 GMT

• iovance climbs after fda rejection for replimune’s skin cancer drug MSN Fri, 03 Jul 2026 15:46:53 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Fri, 03 Jul 2026 11:10:39 GMT

• repl vs iova: fda decision day could test biotech bulls’ conviction on these melanoma plays Stocktwits Fri, 03 Jul 2026 04:04:42 GMT

• Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL) and Roche Holding AG (OtherRHHVF) The Globe and Mail Wed, 01 Jul 2026 07:00:00 GMT

• repl maintains neutral rating by wedbush -- price target raised to $9.00 GuruFocus Tue, 30 Jun 2026 15:23:12 GMT

• Replimune: Stock Buoyant On Third Try At RP1 Approval - FDA AdCom May Be Crucial (REPL) Seeking Alpha Tue, 30 Jun 2026 14:09:50 GMT

• Replimune (REPL) Receives Double Upgrade Amid Positive FDA Devel GuruFocus Tue, 30 Jun 2026 11:56:00 GMT

• bmo capital upgrades replimune to outperform from underperform, adjusts pt to $16 from $1 marketscreener.com Tue, 30 Jun 2026 10:33:48 GMT

• symbol__ stock quote price and forecast CNN Tue, 30 Jun 2026 07:49:52 GMT

• BMO upgrades Replimune stock rating on FDA filing progress Investing.com Tue, 30 Jun 2026 07:00:00 GMT

• Replimune Group, Inc. Stock 12‑Month Price Target Raised to $8.17, Implies 30% Downside TradingView Mon, 29 Jun 2026 22:20:05 GMT

• Replimune's Fiscal Q4 Net Loss Narrows Moomoo Mon, 29 Jun 2026 19:02:02 GMT

• replimune gets fda review for melanoma drug after prior setbacks The Pharma Letter Mon, 29 Jun 2026 12:58:22 GMT

• replimune (nasdaq: repl) outlines rp1 melanoma data and high-stakes fda review Stock Titan Mon, 29 Jun 2026 12:13:21 GMT

• Replimune Group reports FY2026 net loss $313.9M, cash $268.9M, FDA accepts RP1 BLA resubmission TradingView Mon, 29 Jun 2026 12:13:01 GMT

• replimune reports fiscal fourth quarter and year end 2026 financial results and provides corporate update The Manila Times Mon, 29 Jun 2026 12:05:43 GMT

• Replimune’s melanoma drug review moves toward Aug. 2 FDA decision Stock Titan Mon, 29 Jun 2026 12:00:00 GMT

• Press Release: Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update Moomoo Mon, 29 Jun 2026 12:00:00 GMT

• replimune reports fiscal 2026 results and fda bla progress for rp1 in melanoma grafa.com Mon, 29 Jun 2026 08:00:00 GMT

• Replimune Group FY 2026: Revenue $0 Net loss $(313.9)M — 10-K Summary TradingView Mon, 29 Jun 2026 07:00:00 GMT

• Replimune (REPL) widens FY 2026 loss as FDA accepts RP1 melanoma BLA Stock Titan Mon, 29 Jun 2026 07:00:00 GMT

• Replimune Group Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Mon, 29 Jun 2026 07:00:00 GMT

• Replimune Group, Inc. Auditor Raises 'Going Concern' Doubt marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT

• repl vs iova: fda decision day could test biotech bulls’ conviction on these melanoma plays Stocktwits Sun, 28 Jun 2026 19:29:12 GMT

• replimune group, inc. (repl) class action lawsuit: levi & korsins The National Law Review Sun, 28 Jun 2026 18:12:31 GMT

• lost money on replimune group, inc. (repl)? join class action before september 22, 2025 - contact levi & korsinsky The National Law Review Sun, 28 Jun 2026 17:18:34 GMT

• repl investor alert: bronstein, gewirtz and grossman, llc announc The National Law Review Sun, 28 Jun 2026 16:08:41 GMT

• Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) Shareholde The National Law Review Sun, 28 Jun 2026 15:20:01 GMT

• investor alert: deadline approaching to join replimune group, inc. (repl) class action - contact levi & korsinsky The National Law Review Sun, 28 Jun 2026 15:10:30 GMT

• Replimune upgraded by Analyst with a new price target Quantisnow Sat, 27 Jun 2026 03:24:57 GMT

• repl stock on track to hit all-time lows – here’s why this analyst slashed price target by 85% Stocktwits Sat, 27 Jun 2026 00:48:25 GMT

• replimune (repl) receives upgrade from jpmorgan with increased p GuruFocus Fri, 26 Jun 2026 23:45:21 GMT

• replimune (repl) shares decline after fda advisory committee ann GuruFocus Fri, 26 Jun 2026 23:15:37 GMT

• replimune (repl) receives fda review for advanced melanoma treat GuruFocus Fri, 26 Jun 2026 23:15:00 GMT

• replimune group, inc. stock 12‑month price target raised to $7.67, implies 31% downside TradingView Fri, 26 Jun 2026 19:20:04 GMT

• fda accepts third rp1 bla resubmission for advanced melanoma Dermatology Times Fri, 26 Jun 2026 18:34:45 GMT

• replimune reveals fda acceptance of resubmitted bla for rp1 plus nivolumab grafa.com Fri, 26 Jun 2026 16:30:00 GMT

• JPMorgan Upgrades Replimune Group to Overweight From Neutral, $17 Price Target Moomoo Fri, 26 Jun 2026 15:56:18 GMT

• jpmorgan released its latest research report, significantly upgrading the stock rating of biotechnology company replimune group in... Bitget Fri, 26 Jun 2026 15:55:37 GMT

• replimune’s rp1 melanoma therapy bla resubmission accepted by fda; decision expected august 2026 Minichart Fri, 26 Jun 2026 13:09:00 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Fri, 26 Jun 2026 13:07:41 GMT

• enterprise value to ebitda forward of replimune group, inc. – nasdaq:repl TradingView Fri, 26 Jun 2026 12:42:29 GMT

• replimune says fda accepts melanoma drug resubmission, sets aug. 2 target action date marketscreener.com Fri, 26 Jun 2026 12:39:15 GMT

• Replimune: FDA Accepts RP1 BLA Resubmission with Aug. 2, 2026 Goal Date TradingView Fri, 26 Jun 2026 12:23:01 GMT

• replimune to face adcom panel as lead drug accepted for fda review Seeking Alpha Fri, 26 Jun 2026 12:22:07 GMT

• replimune announces fda acceptance of rp1 biologics license application resubmission for advanced melanoma marketscreener.com Fri, 26 Jun 2026 12:01:18 GMT

• replimune group, inc. actuals & estimates (tradegate:7r8) TradingView Fri, 26 Jun 2026 08:25:33 GMT

• Replimune Group Announces FDA Acceptance for Review of RP1 BLA Resubmission in Advanced Melanoma Quiver Quantitative Fri, 26 Jun 2026 07:00:00 GMT

• [8-K] Replimune Group, Inc. Reports Material Event Stock Titan Fri, 26 Jun 2026 07:00:00 GMT

• Replimune Group Stock Short Interest Falls to 54.56% Quiver Quantitative Fri, 26 Jun 2026 07:00:00 GMT

• FDA accepts Replimune’s melanoma drug review, decision due Aug. 2 Stock Titan Fri, 26 Jun 2026 07:00:00 GMT

• Replimune lead drug accepted for FDA review (REPL:NASDAQ) Seeking Alpha Fri, 26 Jun 2026 07:00:00 GMT

• FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services Yahoo Finance Fri, 26 Jun 2026 07:00:00 GMT

• replimune gets early august decision date for twice-rejected melanoma drug BioSpace Fri, 26 Jun 2026 07:00:00 GMT

• fda accepts replimune’s resubmitted application for rp1 Investing.com Fri, 26 Jun 2026 07:00:00 GMT

• replimune group inc. announced that the u.s. food and drug administration (fda) has officially accepted its resubmitted biologics ... Bitget Fri, 26 Jun 2026 07:00:00 GMT

• price to earnings forward of replimune group, inc. – swb:7r8 TradingView Thu, 25 Jun 2026 17:12:24 GMT

• price to sales forward of replimune group, inc. – nasdaq:repl TradingView Thu, 25 Jun 2026 14:30:36 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Thu, 25 Jun 2026 10:54:33 GMT

• enterprise value to ebit forward of replimune group, inc. – nasdaq:repl TradingView Thu, 25 Jun 2026 09:32:08 GMT

• Price to book forward of Replimune Group, Inc. – NASDAQ:REPL TradingView Thu, 25 Jun 2026 01:49:02 GMT

• enterprise value to revenue forward of replimune group, inc. – nasdaq:repl TradingView Wed, 24 Jun 2026 22:47:51 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Tue, 23 Jun 2026 09:02:14 GMT

• us fda reverses course on regenxbio's rare-disease gene therapy, backs accelerated approval bid Reuters Mon, 22 Jun 2026 14:13:55 GMT

• replimune group inc (repl) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Sun, 21 Jun 2026 20:55:55 GMT

• repl nosedives as fda chief stands firm against melanoma treatment: ‘i don’t work for replimune’ MSN Sat, 20 Jun 2026 18:54:47 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Fri, 19 Jun 2026 20:59:13 GMT

• repl stock on track to hit all-time lows – here’s why this analyst slashed price target by 85% Stocktwits Fri, 19 Jun 2026 12:28:31 GMT

• replimune group inc expected to post a loss of 71 cents a share - earnings preview TradingView Fri, 19 Jun 2026 11:05:12 GMT

• replimune group inc (repl) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:02:45 GMT

• replimune group inc (repl) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 03:07:35 GMT

• replimune group inc (repl) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 23:52:35 GMT

• replimune group inc (repl) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 21:18:50 GMT

• replimune group inc (repl) institutional confidence TradingKey Wed, 17 Jun 2026 21:07:54 GMT

• replimune group inc (repl) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:07:42 GMT

• repl stock shot up 80% today – what’s the deal with fda? MSN Tue, 16 Jun 2026 05:17:21 GMT

• replimune group inc. stock dips amid financial challenges and market pressures timothysykes.com Mon, 15 Jun 2026 20:02:00 GMT

• replimune group (repl) treads water near $8.87 as traders eye key support - mfi divergence newsline.com Mon, 15 Jun 2026 14:35:17 GMT

• Replimune Group Faces Setback as FDA Rejection Tanks Stock timothysykes.com Mon, 15 Jun 2026 07:00:00 GMT

• replimune group inc. faces mixed market reactions amid financial updates timothysykes.com Mon, 15 Jun 2026 07:00:00 GMT

• repl stock on track to hit all-time lows – here’s why this analyst slashed price target by 85% Stocktwits Sat, 13 Jun 2026 22:42:29 GMT

• replimune group (repl) rises 3% as biotech stock holds above key support level - undervalued stocks newsline.com Sat, 13 Jun 2026 17:44:25 GMT

• replimune group (repl) rallies 3% as biotech stock tests key resistance at $9.32 - volatility smirk newsline.com Sat, 13 Jun 2026 14:36:35 GMT

• repl nosedives as fda chief stands firm against melanoma treatment: ‘i don’t work for replimune’ MSN Thu, 11 Jun 2026 23:16:21 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Wed, 10 Jun 2026 23:56:28 GMT

• replimune group stock short interest rises to 56.4% Quiver Quantitative Tue, 09 Jun 2026 07:00:00 GMT

• replimune gets third try at fda approval after makary departure MSN Mon, 08 Jun 2026 18:31:40 GMT

• replimune group q1 2026 earnings: smaller-than-expected loss reflects operational discipline - earnings call q&a newsline.com Mon, 08 Jun 2026 17:30:24 GMT

• replimune got another attempt at lead drug after white house intervention: wsj MSN Mon, 08 Jun 2026 17:29:53 GMT

• repl stock on track to hit all-time lows – here’s why this analyst slashed price target by 85% Stocktwits Mon, 08 Jun 2026 17:26:30 GMT

• repl stock shot up 80% today – what’s the deal with fda? MSN Mon, 08 Jun 2026 14:50:12 GMT

• replimune gets third try at fda approval after makary departure MSN Sun, 07 Jun 2026 08:23:19 GMT

• repl stock shot up 80% today – what’s the deal with fda? MSN Sat, 06 Jun 2026 22:44:43 GMT

• repl stock soars on plans of bla resubmission for melanoma combo drug MSN Sat, 06 Jun 2026 15:43:39 GMT

• repl vs iova: fda decision day could test biotech bulls’ conviction on these melanoma plays Stocktwits Fri, 05 Jun 2026 22:52:42 GMT

• replimune group (repl) slips 4% as biotech volatility weighs on shares - ema signal newsline.com Fri, 05 Jun 2026 20:40:07 GMT

• repl stock shot up 80% today – what’s the deal with fda? MSN Fri, 05 Jun 2026 17:47:58 GMT

• replimune got another attempt at lead drug after white house intervention: wsj MSN Fri, 05 Jun 2026 16:13:10 GMT

• repl stock on track for worst drop in nearly 7 months ahead of fda decision on skin cancer drug Stocktwits Fri, 05 Jun 2026 13:58:38 GMT

• replimune: modeling the coin flip of fda approval Seeking Alpha Fri, 05 Jun 2026 02:24:21 GMT

• repl stock soars on plans of bla resubmission for melanoma combo drug MSN Thu, 04 Jun 2026 16:36:37 GMT

• Replimune: Modeling The Coin Flip Of FDA Approval Seeking Alpha Thu, 04 Jun 2026 07:00:00 GMT

• analysts offer insights on healthcare companies: replimune group (repl), eli lilly & co (lly) and relay therapeutics (rlay) The Globe and Mail Thu, 04 Jun 2026 07:00:00 GMT

• insider sell: christopher sarchi sells 12,000 shares of replimune group inc (repl) GuruFocus Thu, 04 Jun 2026 02:20:08 GMT

• replimune cco sarchi sells $110,880 in stock by investing.com Investing.com Nigeria Thu, 04 Jun 2026 01:37:14 GMT

• replimune cco sarchi sells $110,880 in stock Investing.com Thu, 04 Jun 2026 00:58:44 GMT

• replimune (repl) cco sells 12,000 shares under 10b5-1 plan Stock Titan Thu, 04 Jun 2026 00:46:36 GMT

• replimune surges on plans to resubmit lead drug for fda review MSN Wed, 03 Jun 2026 19:43:09 GMT

• replimune got another attempt at lead drug after white house intervention: wsj MSN Wed, 03 Jun 2026 14:43:35 GMT

• replimune gets third try at fda approval after makary departure MSN Wed, 03 Jun 2026 11:32:22 GMT

• replimune (repl) cco sells 12,000 shares under 10b5-1 plan Stock Titan Wed, 03 Jun 2026 07:00:00 GMT

• replimune cco sarchi sells $110,880 in stock Investing.com Wed, 03 Jun 2026 07:00:00 GMT

• insider sell: christopher sarchi sells 12,000 shares of replimune group inc (repl) GuruFocus Wed, 03 Jun 2026 07:00:00 GMT

• symbol__ stock quote price and forecast CNN Tue, 02 Jun 2026 13:57:35 GMT

• repl maintains rating by wedbush -- price target raised to $6.00 GuruFocus Mon, 01 Jun 2026 21:15:42 GMT

• replimune group is maintained at neutral by wedbush Moomoo Mon, 01 Jun 2026 15:30:00 GMT

• how replimune’s drug got third chance after white house intervention MSN Mon, 01 Jun 2026 08:29:46 GMT

• Replimune Group (REPL) Is Up 77.0% After FDA Prioritizes RP1 Melanoma BLA Resubmission Path - Has The Bull Case Changed? simplywall.st Mon, 01 Jun 2026 07:00:00 GMT

• Why Is REPL Stock Gaining In Pre-Market Today? Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT

• JPMorgan upgrades Replimune stock rating on FDA resubmission path Investing.com Mon, 01 Jun 2026 07:00:00 GMT

• REPL Stock Soars on Plans of BLA Resubmission for Melanoma Combo Drug Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT

• Why Is Replimune Stock Gaining Monday? Benzinga Mon, 01 Jun 2026 07:00:00 GMT

• us fda consistency questions remain as replimune eyes third shot at rp1 approval Citeline News & Insights Mon, 01 Jun 2026 07:00:00 GMT

• palomar holdings, replimune group, snowflake TradingView Mon, 01 Jun 2026 07:00:00 GMT

• replimune plans rp1 bla resubmission The Pharma Letter Mon, 01 Jun 2026 07:00:00 GMT

• replimune group price target raised to $6.00/share from $2.00 by wedbush Moomoo Mon, 01 Jun 2026 07:00:00 GMT

• $replimune (repl.us)$ Moomoo Mon, 01 Jun 2026 00:12:08 GMT

• replimune (repl) reports promising survival data from ignyte tri GuruFocus Sun, 31 May 2026 23:58:21 GMT

• repl technical analysis & stock price forecast Intellectia AI Sun, 31 May 2026 12:35:40 GMT

• replimune presents final first-in-human data for rp2 in advanced solid tumors during oral presentation at the 2026 american societ... The Killeen Daily Herald Sun, 31 May 2026 12:00:00 GMT

• Replimune Group Presents Final First-in-Human Data for RP2 Oncolytic Immunotherapy at ASCO 2026 Quiver Quantitative Sun, 31 May 2026 07:00:00 GMT

• Replimune (REPL) Reports Positive Data from RP2 Trials for Advan GuruFocus Sun, 31 May 2026 07:00:00 GMT

• cancer therapy rp2 shrank tumors in first-in-human trial Stock Titan Sun, 31 May 2026 07:00:00 GMT

• how replimune’s drug got third chance after white house intervention MSN Sat, 30 May 2026 15:22:24 GMT

• replimune got another attempt at lead drug after white house intervention: wsj MSN Sat, 30 May 2026 13:27:34 GMT

• Replimune gets third chance at US approval for skin cancer drug Reuters Sat, 30 May 2026 07:00:00 GMT

• Nearly half of anti-PD-1-failed melanoma alive 3 years with Replimune combo Stock Titan Sat, 30 May 2026 07:00:00 GMT

Replimune Group, Inc
(NASDAQ:REPL)

Replimune Group, Inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. It uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a...

Website: http://www.replimune.com

Founded: 2015

Full Time Employees: 122

Sector: Healthcare

Industry: Biotechnology

Pharmaceuticals

Share this website to your friends

Replimune Group, Inc(NASDAQ:REPL)

Replimune Group, Inc
(NASDAQ:REPL)